Skip to content

The usefulness of 11C-flumazenil PET in patients with mesial temporal lobe epilepsy

The usefulness of 11C-flumazenil PET in patients with mesial temporal lobe epilepsy - The usefulness of 11C-flumazenil PET in patients with mesial temporal lobe epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000005273
Enrollment
40
Registered
2011-03-19
Start date
2011-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mesial temporal lobe epilepsy

Interventions

None listed

Sponsors

Hiroshima University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with intractable mesial temporal lobe epilepsy

Exclusion criteria

Exclusion criteria: patients that their epileptic foci are clealy known

Design outcomes

Primary

MeasureTime frame
To demonstrate the usefulness of 11C-flumazenil PET in patients with mesial temporal lobe epilepsy

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026